Ivy Chung

2.4k total citations
55 papers, 1.9k citations indexed

About

Ivy Chung is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ivy Chung has authored 55 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 17 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Ivy Chung's work include Cancer Cells and Metastasis (11 papers), Cancer, Hypoxia, and Metabolism (8 papers) and MicroRNA in disease regulation (7 papers). Ivy Chung is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Cancer, Hypoxia, and Metabolism (8 papers) and MicroRNA in disease regulation (7 papers). Ivy Chung collaborates with scholars based in Malaysia, United States and Japan. Ivy Chung's co-authors include Bruce R. Zetter, Candace S. Johnson, Donald L. Trump, Noor Azmi Mat Adenan, Yin Ling Woo, Zahurin Mohamed, Yuan Seng Wu, Atsushi Masamune, Rachelle R. Olsen and Weidong Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Ivy Chung

55 papers receiving 1.9k citations

Peers

Ivy Chung
Hui Song China
Eun Y. Lee United States
Yvette N. Lamb New Zealand
Masood A. Shammas United States
Hermes Garbán United States
Sushanta K. Banerjee United States
Kathryn L. Terry United States
Hongmei Nan United States
Arup Chakraborty United States
Hui Song China
Ivy Chung
Citations per year, relative to Ivy Chung Ivy Chung (= 1×) peers Hui Song

Countries citing papers authored by Ivy Chung

Since Specialization
Citations

This map shows the geographic impact of Ivy Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivy Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivy Chung more than expected).

Fields of papers citing papers by Ivy Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivy Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivy Chung. The network helps show where Ivy Chung may publish in the future.

Co-authorship network of co-authors of Ivy Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Ivy Chung. A scholar is included among the top collaborators of Ivy Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivy Chung. Ivy Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jamil, Amira Hajirah Abd, et al.. (2025). Linking microRNA to metabolic reprogramming and gut microbiota in the pathogenesis of colorectal cancer (Review). International Journal of Molecular Medicine. 55(3). 1 indexed citations
2.
Leo, Bey Fen, Yin Yin Teo, Ivy Chung, et al.. (2022). Chitosan-Coated-PLGA Nanoparticles Enhance the Antitumor and Antimigration Activity of Stattic – A STAT3 Dimerization Blocker. Dove Medical Press (Taylor and Francis Group). 29 indexed citations
3.
Jamil, Amira Hajirah Abd, et al.. (2022). MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling. PLoS ONE. 17(7). e0270830–e0270830. 3 indexed citations
4.
Chung, Ivy, et al.. (2022). The role of tumour microenvironment-driven miRNAs in the chemoresistance of muscle-invasive bladder cancer–a review. Urologic Oncology Seminars and Original Investigations. 40(4). 133–148. 2 indexed citations
5.
Chung, Ivy, et al.. (2021). Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review. Chinese Medicine. 16(1). 15–15. 15 indexed citations
6.
Wong, Li Ping, Haridah Alias, Maw Pin Tan, et al.. (2021). Escalating progression of mental health disorders during the COVID-19 pandemic: Evidence from a nationwide survey. PLoS ONE. 16(3). e0248916–e0248916. 88 indexed citations
7.
Wong, Li Ping, et al.. (2020). Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia. The Journal of Headache and Pain. 21(1). 68–68. 29 indexed citations
8.
Jamil, Amira Hajirah Abd, et al.. (2020). Fatty acid binding protein 7 mediates linoleic acid-induced cell death in triple negative breast cancer cells by modulating 13-HODE. Biochimie. 179. 23–31. 11 indexed citations
9.
Chung, Ivy, et al.. (2020). MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 28(6). 615–629. 9 indexed citations
10.
Tan, May, Max Robinson, Maha Ibrahim, et al.. (2019). Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1. Cancers. 11(11). 1766–1766. 43 indexed citations
11.
Chung, Ivy, et al.. (2017). Annonacin exerts antitumor activity through induction of apoptosis and extracellular signal-regulated kinase inhibition. Pharmacognosy Research. 9(4). 378–378. 20 indexed citations
12.
Banyard, Jacqueline, et al.. (2014). Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer. BMC Cancer. 14(1). 387–387. 48 indexed citations
13.
Fung, Shin Yee, et al.. (2014). King Cobra (Ophiophagus hannah) Venom L-Amino Acid Oxidase Induces Apoptosis in PC-3 Cells and Suppresses PC-3 Solid Tumor Growth in a Tumor Xenograft Mouse Model. International Journal of Medical Sciences. 11(6). 593–601. 42 indexed citations
14.
Zhang, Yaqing, Wei Yan, Meredith A. Collins, et al.. (2013). Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance. Cancer Research. 73(20). 6359–6374. 197 indexed citations
15.
Sattar, Munavvar Zubaid Abdul, et al.. (2013). Antioxidant and pro-oxidant effects of oil palm (Elaeis guineensis) leaves extract in experimental diabetic nephropathy: a duration-dependent outcome. BMC Complementary and Alternative Medicine. 13(1). 242–242. 18 indexed citations
16.
Mohamed, Zahurin, et al.. (2013). Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells. PLoS ONE. 8(7). e68923–e68923. 92 indexed citations
17.
Olsen, Rachelle R., Ivy Chung, & Bruce R. Zetter. (2011). Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo. Amino Acids. 42(2-3). 549–558. 13 indexed citations
18.
Haar-Holleman, Amy de, Ivy Chung, Rachelle R. Olsen, et al.. (2011). miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene. 30(43). 4386–4398. 87 indexed citations
19.
Chung, Ivy, Adam R. Karpf, Geraldine Flynn, et al.. (2007). Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 768–770. 16 indexed citations
20.
Chung, Ivy, Adam R. Karpf, Josephia R. Muindi, et al.. (2007). Epigenetic Silencing of CYP24 in Tumor-derived Endothelial Cells Contributes to Selective Growth Inhibition by Calcitriol. Journal of Biological Chemistry. 282(12). 8704–8714. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026